
Search Clinical Trials
The U.S. National Library of Medicine provides a database of clinical trials worldwide. Use the fields below to search the database. Expand your results and select terms or phrases and right-click to search using Google, MalaCards, MedlinePlus, PubMed, or Wikipedia.
Saved Searches
Choose Search
Basic Search
Clinical Trials Search Results
Search History:
Count: 276
Selected: 0
NCT ID | Title | ||
---|---|---|---|
NCT00216879 | Efficacy and Safety of Calcipotriol Plus Betamethasone Dipropionate Gel for up to a Year in Scalp Psoriasis | ||
NCT05050279 | A Trial to Evaluate the Effect of Delgocitinib on the Heart Rhythm of Healthy People | ||
NCT02748902 | Exploratory Study of Efficacy and Safety of Ingenol Mebutate 0.05% Gel for Common Warts on the Hands. | ||
NCT00851864 | Safety and Efficacy of Therapeutic Anticoagulation With Tinzaparin During Pregnancy Via Weight-based Dosing | ||
NCT00243464 | Efficacy of Calcipotriol Plus Betamethasone Gel Versus Calcipotriol Scalp Solution in Scalp Psoriasis | ||
NCT05098821 | Extrinsic and Intrinsic Factors in Atopic Dermatitis Upon Systemic Immune Modulation | ||
NCT04922021 | An Evaluation of LEO 138559 in Adults With Moderate to Severe Atopic Dermatitis. | ||
NCT00691002 | Efficacy and Safety of Calcipotriol Plus Hydrocortisone Ointment in Psoriasis Vulgaris on the Face and Skin Folds | ||
NCT01998984 | Efficacy and Safety of Ingenol Mebutate Gel 0.06% When Applied Once Daily for 2, 3 or 4 Consecutive Days to a Treatment Area of Approximately 250 cm2 on Trunk and Extremities in Subjects With Actinic Keratosis | ||
NCT01141179 | The Impact of Renal Impairment on the Pharmacokinetic and Pharmacodynamic of LEO 27847 | ||
NCT01211964 | LEO 22811 - Single Dose Bioavailability Study of Tablet Versus Oral Solution in Healthy Subjects | ||
NCT01701843 | Cromoglicate in Mastocytosis | ||
NCT00252408 | Danish Osteoporosis Prevention Study | ||
NCT01536938 | LEO 90100 in the Treatment of Psoriasis Vulgaris | ||
NCT06773455 | Tralokinumab for Dupilumab Failures | ||
NCT01600014 | Ingenol Mebutate Gel, 0.015% Repeat Use for Multiple Actinic Keratoses on Face and Scalp | ||
NCT03995550 | Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics After Single and Multiple Doses of LEO 142397 in Healthy People, Including Japanese | ||
NCT01922050 | A Study of Increasing Strengths, Safety and Efficacy of Two Formulas of LEO 43204 on the Face or the Chest in Patients With Actinic Keratosis | ||
NCT06004050 | A Trial to Evaluate Efficacy, Safety, and Pharmacokinetics of Delgocitinib Cream in Chinese Adults and Adolescents With Moderate to Severe Chronic Hand Eczema | ||
NCT02446223 | Evaluate the Efficacy and Safety of Large-Scale Field-Directed Topical Therapy of Actinic Keratosis of the Chest w/Ingenol Mebutate 0.015% | ||
NCT01116895 | A Proof of Concept Study Comparing Three Doses of an Oral Solution of LEO 22811 With a Placebo Oral Solution for the Treatment of Psoriasis Vulgaris | ||
NCT01947738 | Safety Study of VBY-891 in Healthy Volunteers After Single or Multiple (7 Days) of Oral Dosing (VBY891P1) | ||
NCT00711308 | Tinzaparin in the Treatment of the Acute Pulmonary Embolism | ||
NCT05470114 | A Multi-omics Disease Signature Trial in Adult Patients With Moderate to Severe AD | ||
NCT00617903 | Exploration of Safety and Efficacy of AzA 15% Foam Twice a Day in Rosacea | ||
NCT03806790 | Efficacy and Safety of LEO 90100 Foam in Japanese Subjects With Psoriasis Vulgaris | ||
NCT01707043 | Patient Preference of Taclonex Ointment to Taclonex Scalp Suspension in Adult Subjects With Psoriasis Vulgaris | ||
NCT02496546 | An Explorative Trial Evaluating the Effect of LEO 32731 Cream in Adults With Mild to Moderate Atopic Dermatitis (AD) | ||
NCT04794569 | Tinzaparin Lead-In to Prevent the Post-Thrombotic Syndrome | ||
NCT01935869 | Combined Cumulative Irritation Potential and Repeat Insult Patch Test of LEO 90100 | ||
NCT02881346 | Efficacy and Tolerability of Enstilar® in Daily Practice | ||
NCT03476746 | Dermatopharmacokinetic Trial of LEO 90100 Foam | ||
NCT02038569 | An International, Multi-centre, Prospective, Non-controlled, Open, Single-group, 8-week Trial in Adolescent Subjects | ||
NCT01707368 | Non-interventional Study of Long-term Treatment of Psoriasis With Calcipotriol Plus Betamethasone in Gel Formulation | ||
NCT03336372 | Picato for the Treatment of Molluscum Contagiosum in Immunocompromised Patients | ||
NCT00833872 | LEO 22811 - A Phase 1, Double-Blind, Placebo-controlled, Single and Multiple Oral Dose Study in Healthy Subjects | ||
NCT00185510 | Efficacy and Safety Study of Advantan for Maintenance Treatment of Atopic Dermatitis | ||
NCT06311682 | A Trial to Evaluate the Efficacy and Safety of Tralokinumab in Combination With Topical Corticosteroids in Children and Infants With Moderate-to-severe Atopic Dermatitis | ||
NCT00689520 | Long-Term Low-Molecular-Weight Heparin Versus Oral Anticoagulants in Deep Venous Thrombosis | ||
NCT05508776 | A Trial to Evaluate the Effect of LEO 152020 on the Heart of Healthy People | ||
NCT04305327 | Efficacy and Safety of Brodalumab in Adolescents From 12 to 17 Years of Age With Moderate-to-severe Plaque Psoriasis | ||
NCT03827876 | Enstilar in Combination With Enbrel or Humira for Plaque Psoriasis | ||
NCT05332366 | A Trial to Assess the Effect of Delgocitinib Cream 20 mg/g on the Molecular Signature, Safety, and Efficacy in Adults With Frontal Fibrosing Alopecia | ||
NCT03673527 | Tacrolimus Blood Levels After Topical Application of Tacrolimus on Healthy Skin | ||
NCT01320774 | Efficacy, Tolerability and Handling of Daivobet® Gel in Patients With Psoriasis Vulgaris | ||
NCT00742482 | Efficacy and Safety of 3 Doses of HL10 Given at Fixed Time Intervals Compared to Standard Therapy | ||
NCT02695940 | Trial Twice Daily Application of LEO 124249 Ointment 30 mg/g in Treatment of Mild to Moderate Inverse Psoriasis | ||
NCT03710044 | Investigation of Flare and Remission in Subjects With Atopic Dermatitis | ||
NCT00216840 | Efficacy and Safety of Calcipotriol Plus Betamethasone Dipropionate Gel in Scalp Psoriasis | ||
NCT03826901 | Delgocitinib Cream for the Treatment of Moderate to Severe Atopic Dermatitis During 8 Weeks in Adults, Adolescents, and Children |